Novartis’ CAR-T therapy was the very first approved in U.S. — here’s how to invest in the space

Published: Sept Five, two thousand seventeen 6:58 a.m. ET

Companies that provide services and solutions to cell therapy companies will become invaluable, says Janney analyst Knight

EmmaCourt

On Wednesday, the very first of a fresh type of cancer-fighting cell therapy called CAR-T was approved in the U.S.: Novartis AG’s Kymriah, intended to treat youthful people with acute lymphoblastic leukemia. Continue reading Novartis’ CAR-T therapy was the very first approved in U